Tag - vaccines

 
 

VACCINES

Japan Times
WORLD / Science & Health / FOCUS
Aug 31, 2020
Scientists see downsides to top COVID-19 vaccines from Russia and China
High-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their effectiveness, some experts say.
JAPAN / Science & Health
Aug 31, 2020
Daiichi Sankyo's COVID-19 vaccine candidate selected by Japanese drug discovery body
Daiichi Sankyo Co. said on Monday that its mRNA-based COVID-19 vaccine candidate was selected for inclusion in a drug discovery program by the Japan Agency for Medical Research and Development.
Japan Times
WORLD / Science & Health
Aug 29, 2020
First U.S. novel coronavirus reinfection case identified in Nevada study
Researchers for the first time have identified someone in the United States who was reinfected with the novel coronavirus, according to a study that has not yet been reviewed by outside experts.
Japan Times
JAPAN / Society
Aug 28, 2020
Abe vows COVID-19 vaccinations for all Japan citizens by mid-2021
In view of the coming flu season, test kits will be provided at a volume that will allow for an average of 200,000 tests to be conducted every day.
Japan Times
BUSINESS / Economy
Aug 27, 2020
Coronavirus vaccine could spark Japan recovery by 2022, economist says
Columbia University professor Takatoshi Ito says data is already signaling that Japan is bouncing back.
Japan Times
WORLD / Science & Health / FOCUS
Aug 26, 2020
Developing countries don’t want to wait for superpowers’ vaccines
After COVID-19’s emergence in Buenos Aires led to a strict lockdown in March, Juliana Cassataro and her fellow vaccine researchers grew concerned. The U.S., Europe and China had already revved up their quests to obtain shots; how far back in line would Argentina have to wait for supplies?
Japan Times
WORLD / Science & Health
Aug 22, 2020
New antibody tests offer better snapshot of COVID-19 immunity
A new crop of COVID-19 antibody tests measures the level of protection someone has built up against the deadly virus and may help determine which vaccines are most effective.
Japan Times
WORLD / Science & Health
Aug 16, 2020
Coronavirus crisis has made Brazil an ideal vaccine laboratory
With a medical manufacturing infrastructure and plenty of vaccine trial volunteers, Brazil has emerged as a potentially vital player in the scramble to end the pandemic.
Japan Times
JAPAN / Science & Health
Aug 14, 2020
Coronavirus antibodies disappear in months. Is that a cause for concern?
Research has poured cold water on the optimism of those who have been working around the clock to produce vaccines against the disease.
Japan Times
COMMENTARY / World
Aug 10, 2020
Vaccine confronts humanity with next moral test
Who gets coronavirus protection first (and last)? Who profits (and loses)? What is “informed consent” (if it exists)? Divided societies face agonizing choices.
Japan Times
WORLD
Aug 7, 2020
Facebook’s dilemma: How to police claims about unproven virus vaccines
Since the World Health Organization declared the novel coronavirus an international health emergency in January, Facebook Inc. has removed more than 7 million pieces of content with false claims about the virus that could pose an immediate health risk to people who believe them.
Japan Times
COMMENTARY / World
Aug 5, 2020
Pricing COVID-19 vaccines too high could backfire on big pharma
If vaccine makers make their products too expensive for the developing world, the whole idea of intellectual property could be blown up.
Japan Times
WORLD
Aug 3, 2020
There may never be a 'silver bullet' for COVID-19, WHO warns
The World Health Organization warned on Monday that, despite strong hopes for a vaccine, there might never be a "silver bullet" for COVID-19, and the road to normality would be long.
Japan Times
WORLD / Science & Health
Aug 2, 2020
When it comes to COVID-19 vaccines, rich nations are first in line
Wealthy countries have already locked up more than a billion doses of coronavirus vaccines, raising worries that the rest of the world will be at the back of the queue in the global effort to defeat the pathogen.
Japan Times
BUSINESS / Economy
Aug 1, 2020
World economy’s sputtering recovery threatened by flaring coronavirus
The Asia-Pacific region has been hit hard by a resurgence in the number of COVID-19 cases in recent weeks.
Japan Times
WORLD / Science & Health
Jul 30, 2020
Russia plans 'world's first approved' COVID-19 vaccine by Aug. 12
The conditional registration in August would still require trials to be conducted on another 1,600 people, and production is expected to begin in September.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?